The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
The drug, suzetrigine, made by Boston-based Vertex Pharmaceuticals and to be sold as Journavx, works only on nerves outside ...
The drug represents a new pathway to treating people with pain due to surgeries or traumatic injuries, avoiding the addictive ...
FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.